The British Cardiac Society Working Group definition of myocardial infarction: Implications for practice

Heart

Volumn 92, Issue 1, 2006, Pages 21-26

  Das, R ^a   Kilcullen, N ^a   Morrell, C ^a   Robinson, M B ^a   Barth, J H ^b   Hall, Alistair S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; STATISTICAL ANALYSIS; UNITED KINGDOM;

AGED; ENGLAND; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 29644446915     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.046441     Document Type: Article

References (20)

1. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus documentor tfie Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
2. World Health Organization. Working Group on the establishment of ischemic heart disease registers. Report of the Fifth Working Group, Copenhagen. WHO Reg Publ Eur Ser, 1972;821(suppl 5).
3. Joint International Society and Federation of Cardiology/World Health Organization. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979;59:607-9.
4. Fox KA, Birkhead J, Wilcox R, et al. British Cardiac Society Working Group on the definition of myocardial infarction. Heart 2004;90:603-9.
5. Newby LK, Alpert JS, Ohman EM, et al. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. Am Heart J 2002;144:957-80.
6. White HD. Things ain't what they used to be: impact of a new definition of myocardial infarction [editorial]. Am Heart J 2002;144:933-7.
7. Apple FS, Wu AHB, Jaffe AS. European Society of cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002;144:981-6.
8. Meier MA, Al-Badr WH, Cooper JV, et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002;162:1585-9.
9. Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force of the European Society of Cardiology. Eur Heart J 2002;23:1809-40.
10. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
11. Fox KAA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome: Findings from the global registry of acute coronary events (GRACE) study. Eur Heart J 2002;23:1177-89.
12. FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and fast revascularisation during instability in coronary artery disease investigators. Lancet 1999;354:708-15.
13. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban, N Engl J Med 2001;344:1879-87.
14. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J Am Coll Cardiol 2000;36:970-1062.
15. Bavry AA, Kumbhani DJ, Quiroz R, et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 2004;93:830-5.
16. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
17. Morrow DA, Antman EM, Snapinn S, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002;23:223-9.
18. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 2001;345:494-502.
19. National Institute for Clinical Excellence. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes, Technology Appraisal Guidance No 47. London: NICE, 2002.
20. Pell JP, Simpson E, Rodger JC, et al. Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. BMJ 2003;326:134-5.